Atara Biotherapeutics Files Prospectus For Offering $79.3M Common Shares

Benzinga Newsdesk www.benzinga.com Neutral 92.3%

Neg 0% Neu 92.3% Pos 0%

https://www.sec.gov/Archives/edgar/data/1604464/000119312526219518/atra-424-b5-2026_q2.htm

Comments

No comments yet. Be the first!